Back to Search
DERRICK CHUA, D.M.D.
D.M.D.
General Practice Dentistry
NPI: 1538102256Individual
Specialties, Licenses & Credentials
General Practice DentistryPrimary
Dentist — General Practice
Code: 1223G0001X
52843(CA)
Research & Publications (20)
Comparison of single versus fractionated dose of stereotactic radiotherapy for salvaging local failures of nasopharyngeal carcinoma: a matched-cohort analysis.
PMID 19463191·Head Neck Oncol·2009
4-observational
Validation of a prognostic scoring system for locally recurrent nasopharyngeal carcinoma treated by stereotactic radiosurgery.
PMID 19402900·BMC Cancer·2009
8-other
Characterization of a novel epigenetically-silenced, growth-suppressive gene, ADAMTS9, and its association with lymph node metastases in nasopharyngeal carcinoma.
PMID 18449890·Int J Cancer·2008
8-other
Capecitabine monotherapy for recurrent and metastatic nasopharyngeal cancer.
PMID 18407933·Jpn J Clin Oncol·2008
8-other
Phase II study of gefitinib for the treatment of recurrent and metastatic nasopharyngeal carcinoma.
PMID 18213730·Head Neck·2008
3-trial
Late oral complications following radiotherapy for head and neck cancers.
PMID 17892422·Expert Rev Anticancer Ther·2007
6-review
Stereotactic radiosurgery versus gold grain implantation in salvaging local failures of nasopharyngeal carcinoma.
PMID 17869663·Int J Radiat Oncol Biol Phys·2007
4-observational
Statins and progression of calcified aortic stenosis.
PMID 17132803·Ann Pharmacother·2006
4-observational
Predictive factors of tumor control and survival after radiosurgery for local failures of nasopharyngeal carcinoma.
PMID 17056191·Int J Radiat Oncol Biol Phys·2006
8-other
Improvement of survival after addition of induction chemotherapy to radiotherapy in patients with early-stage nasopharyngeal carcinoma: Subgroup analysis of two Phase III trials.
PMID 16750333·Int J Radiat Oncol Biol Phys·2006
3-trial
Re-irradiation of nasopharyngeal carcinoma with intensity-modulated radiotherapy.
PMID 16289398·Radiother Oncol·2005
3-trial
Induction chemotherapy with cisplatin and gemcitabine followed by reirradiation for locally recurrent nasopharyngeal carcinoma.
PMID 16199985·Am J Clin Oncol·2005
8-other
A phase II study of docetaxel and cisplatin as first-line chemotherapy in patients with metastatic nasopharyngeal carcinoma.
PMID 15975521·Oral Oncol·2005
3-trial
Long-term survival after cisplatin-based induction chemotherapy and radiotherapy for nasopharyngeal carcinoma: a pooled data analysis of two phase III trials.
PMID 15657403·J Clin Oncol·2005
4-observational
Clinical implications of blockade of the renin-angiotensin system in management of hypertension.
PMID 15248359·Contrib Nephrol·2004
6-review
Prognostic impact of hemoglobin levels on treatment outcome in patients with nasopharyngeal carcinoma treated with sequential chemoradiotherapy or radiotherapy alone.
PMID 15241828·Cancer·2004
3-trial
Prognostic value of epidermal growth factor receptor expression in patients with advanced stage nasopharyngeal carcinoma treated with induction chemotherapy and radiotherapy.
PMID 15093894·Int J Radiat Oncol Biol Phys·2004
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2489 MISSION ST, STE 12
SAN FRANCISCO, CA 94110 - Phone
- (415) 282-6810
Quick Facts
- NPI
- 1538102256
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile